Detalhe da pesquisa
1.
Detecting measurable residual disease beyond 10-4 by an IGHV leader-based NGS approach improves prognostic stratification in CLL.
Blood
; 141(5): 519-528, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36084320
2.
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
Blood
; 142(13): 1131-1142, 2023 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37363833
3.
Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis.
Blood
; 142(16): 1399-1403, 2023 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37523714
4.
Possible hampered effectiveness of second-line treatment with rituximab-containing chemotherapy without signs of rituximab resistance: a population-based study among patients with chronic lymphocytic leukemia.
Ann Hematol
; 99(5): 1081-1091, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32193628
5.
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia.
Haematologica
; 104(1): 147-154, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115656
6.
Survival continues to increase in chronic lymphocytic leukaemia: a population-based analysis among 20 468 patients diagnosed in the Netherlands between 1989 and 2016.
Br J Haematol
; 189(3): 574-577, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31958141
7.
The effectiveness of ibrutinib in chronic lymphocytic leukaemia: a nationwide, population-based study in the Netherlands.
Br J Haematol
; 188(6): e109-e112, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31991479
8.
Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019.
Blood Cancer J
; 13(1): 15, 2023 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36635262
9.
High-throughput Proteomics Identifies THEMIS2 as Independent Biomarker of Treatment-free Survival in Untreated CLL.
Hemasphere
; 7(10): e951, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731707
10.
Conditional relative survival among patients with chronic lymphocytic leukaemia: A population-based study in the Netherlands.
EJHaem
; 3(1): 180-183, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846209
11.
Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group.
Leuk Lymphoma
; 63(10): 2276-2289, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737364
12.
Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features.
Front Oncol
; 11: 780085, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34956898
13.
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study.
Exp Hematol
; 89: 55-60.e6, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32781097
14.
Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2018.
Blood Cancer J
; 12(4): 72, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35444185
15.
Rituximab addition to chemotherapy in real world patients with chronic lymphocytic leukemia: effective in first line but indication of lack of efficacy in subsequent lines of therapy.
Leuk Lymphoma
; 59(11): 2757-2761, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29616852
16.
High coincidence of chronic lymphocytic leukemia and myeloproliferative neoplasms: detection bias or a clue to a common pathophysiological path?
Leuk Lymphoma
; 58(3): 756-757, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27908226